BACKGROUND Company: Top 50 pharmaceutical company Indication: Pulmonary embolism Phase(s): Proof of concept and validation CHALLENGE The sponsor was struggling to objectively and reproducibly measure the location and concentration of their imaging drug (e.g., contrast agent). They also wanted a better way to visualize and detect pulmonary emboli. To achieve this, ERT was engaged to develop a software-based image processing and analysis method to use with contrast-enhanced computed tomography (CT) imaging. Imaging technology that delivers results without the typical human bias. To learn more, go to ert.com info@ert.com. RESULTS The sponsor was able to implement ERT’s image acquisition protocol (IAP), image evaluation protocol (IEP) and image processing and analysis software to: > Mea

Join for free to read